Pegylated Phospholipid Nanomicelles Containing Budesonide Or Beclimethasone Dipropionate For Pulmonary Delivery

Sahib, Mohanad Naji (2011) Pegylated Phospholipid Nanomicelles Containing Budesonide Or Beclimethasone Dipropionate For Pulmonary Delivery. PhD thesis, Universiti Sains Malaysia.

[img]
Preview
PDF
Download (268kB) | Preview

Abstract

The aims of the present study were to formulate and evaluate nanomicelles containing poorly water soluble corticosteroids, budesonide (BUD) or beclomethasone dipropionate (BDP) for pulmonary delivery using PEGylated polymers (PEG5000-DSPE and PEG2000-DSPE). All the sterically stabilized phospholipid nanomicelles (SSMs) were successfully prepared using a co-precipitation and reconstitution method. The SSMs were characterised by different physicochemical methods. There were significant differences between the maximum solubilisation tendencies of PEG5000-DSPE and PEG2000-DSPE for BUD, which were approximately 605.71±6.38 and 646.27±4.93 μg/ml, respectively. The maximum solubilisation tendencies of PEG5000-DSPE and PEG2000-DSPE for BDP were approximately 209.65±7.74 and 210.01±5.28, respectively. These results showed that PEGylated polymers had greater tendencies to solubilise BUD than BDP. The mean particle sizes at maximum solubilisation of BUD:PEG2000-DSPE (15.97±1.91 nm) and BDP:PEG2000-DSPE (15.44±1.66 nm) were smaller than BUD:PEG5000-DSPE (20.45±1.65 nm) and BDP:PEG5000-DSPE (19.99±0.98 nm). Blank SSMs of PEG5000-DSPE were successfully lyophilised at a concentration of about 5 mM, while 10 mM of PEG2000-DSPE was needed for lyophilisation.

Item Type: Thesis (PhD)
Subjects: R Medicine > RS Pharmacy and materia medica > RS1-441 Pharmacy and materia medica
Divisions: Pusat Pengajian Sains Farmasi (School of Pharmacy) > Thesis
Depositing User: HJ Hazwani Jamaluddin
Date Deposited: 20 Feb 2020 07:25
Last Modified: 20 Feb 2020 07:25
URI: http://eprints.usm.my/id/eprint/46297

Actions (login required)

View Item View Item
Share